Examination of the Large Intestine With Camera Capsule in Patients With Blood Stream Infection With Gut-associated Bacteria
NCT06919068
Summary
The goal of this observational study is to diagnose colorectal cancer or precancerous tumors in participants over the age of 18 hospitalized with blood stream infection with anaerobic gut-associated bacteria. The main question it aims to answer is: • How prevalent is cancer and precancerous tumors in the large intestines and rectum in patients with anaerobic bacteremia? Participants will be offered an examination using colon capsule endoscopy 4-8 weeks after discharge.
Eligibility
Inclusion Criteria: * Older than 18 years * Blood culture with growth of one or more of the following bacterial genera Bacteroides, Clostridium, Filifactor, Fusobacterium, Gemella, Granulicatella, Parvimonas, Peptostreptococcus, Prevotella, Solobacterium, Peptoniphilus, Ruminococcus, Finegoldia and Streptococcus. * Able to provide oral and written informed consent * Able to read and speak Danish Exclusion Criteria: * Prior colorectal cancer diagnosis * History of stenosis of the gastrointestinal tract * Previous treatment of inflammatory bowel disease * Previous major surgery of the gastrointesinal tract (e.g. gastric bypass) * Colostomy * Pacemaker/ICD * Pregnancy or breastfeeding * Allergies to the bowel preparation regimen * Severe kidney disease * Focus of infection in skin and soft tissue or outside the truncus (e.g. decubitus, diabetic foot ulcer) * Tumor in the colon or rectum at diagnostic imaging * Transfer to other hospital outside the region
Conditions6
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06919068